Cannabinoid hyperemesis syndrome

Cannabinoid hyperemesis syndrome
Classification and external resources
Specialty Toxicology

Cannabinoid hyperemesis syndrome is characterized by recurrent nausea, vomiting and crampy abdominal pain. These symptoms have been reported to be improved temporarily by taking a hot shower or bath or more fully by stopping the use of cannabis.

The syndrome was described by Allen and colleagues (2004), and Sontineni and colleagues (2009) who offer simplified clinical diagnostic criteria.[1][2] A subsequent, larger study reported a case series of 98 subjects with cannabinoid hyperemesis syndrome, confirming the earlier reported findings.[3]

Signs and symptoms

Sontineni criteria[2]
Essential Cannabis use for years
Major Severe nausea and vomiting

Vomiting that recurs in a cyclic pattern over months

Resolution of symptoms after stopping cannabis use.

Supportive Compulsive hot baths with symptom relief

Colicky abdominal pain

No evidence of gall bladder or pancreatic inflammation

Modified criteria[3]
Essential Long-term cannabis use
Major Severe cyclic nausea and vomiting

Resolution with cannabis cessation

Relief of symptoms with hot showers or baths

Abdominal pain, epigastric or periumbilical

Weekly use of marijuana.

Supportive Age less than 50 y

Weight loss of >5 kg

Morning predominance of symptoms

Normal bowel habits

Negative laboratory, radiographic, and endoscopic test results

The long-term and short-term effects of cannabis use are associated with behavioural effects leading to a wide variety of effects on the body systems and physiologic states.[2]

Sontineni and colleagues in 2009 discussed the cannabinoid hyperemesis syndrome to offer guidelines for the clinical diagnosis.[2]

Individual attacks can lead to complications, such as acute kidney injury.[4]

Pathogenesis

Various pathogenic mechanistic theories attempting to explain symptoms have been put forward. These theories fall into two themes: 1) dose dependent buildup of cannabinoids and related effects of cannabinoid toxicity, and 2) the functionality of cannabinoid receptors in the brain and particularly in the hypothalamus (which regulates body temperature and the digestive system). But the mechanisms by which cannabis causes or controls nausea and the adverse consequences of long-term cannabis toxicity remain unknown and organic disease should not be ruled out as a possible cause.[5]

The neurobiology of the compound has led to the discovery of an endogenous cannabinoid system.[6] The therapeutic potential of cannabinoids has been recognized and these compounds are utilized as antiemetics. Several studies have demonstrated the therapeutic effects of cannabinoids for nausea and vomiting in the advanced stages of illnesses such as cancer and AIDS.[7]

Differential diagnosis

Cyclic vomiting syndrome may present similarly.[8]

Epidemiology

The number of people affect is unclear as of 2015.[9]

History

Cannabinoid hyperemesis was first reported in the Adelaide Hills of South Australia.[1]

Treatment

Many traditional medications for nausea and vomiting are ineffective. However, treatment with lorazepam or haloperidol has provided relief for some people.[10] Assessing for dehydration due to vomiting and hot showers is important as it can lead to cannabinoid hyperemesis acute renal failure (CHARF), and this is easily treated with IV fluids.[11] Treatment is otherwise supportive and focuses on stopping cannabis use.[12]

Prognosis

Acute episodes of cannabinoid hyperemesis typically last for 24–48 hours and the problem often resolves with long term stopping of cannabis use. Improvement can take one to three months to occur.[13]

Relapses are common, and this is thought to be possibly secondary to a lack of education as many people use or increase their use of cannabis to treat their symptoms of nausea and vomiting.[8]

References

  1. 1 2 Allen, J H; De Moore, GM; Heddle, R; Twartz, JC (2004). "Cannabinoid hyperemesis: Cyclical hyperemesis in association with chronic cannabis abuse". Gut 53 (11): 1566–70. doi:10.1136/gut.2003.036350. PMC 1774264. PMID 15479672.
  2. 1 2 3 4 Sontineni, Siva-P; Chaudhary, S; Sontineni, V; Lanspa, SJ (2009). "Cannabinoid hyperemesis syndrome: Clinical diagnosis of an underrecognised manifestation of chronic cannabis abuse". World Journal of Gastroenterology 15 (10): 1264–6. doi:10.3748/wjg.15.1264. PMC 2658859. PMID 19291829.
  3. 1 2 Simonetto, Douglas A.; Oxentenko, Amy S.; Herman, Margot L.; Szostek, Jason H. (2012). "Cannabinoid Hyperemesis: A Case Series of 98 Patients". Mayo Clinic Proceedings 87 (2): 114–9. doi:10.1016/j.mayocp.2011.10.005. PMC 3538402. PMID 22305024.
  4. ↑ Habboushe J, Sedor J (June 2014). "Cannabinoid hyperemesis acute renal failure: a common sequela of cannabinoid hyperemesis syndrome". Am J Emerg Med 32 (6): 690.e1–2. doi:10.1016/j.ajem.2013.12.013. PMID 24418446.
  5. ↑ "NCPIC.Cannabinoid hyperemesis syndrome". Ncpic.org.au. Retrieved 2012-05-24.
  6. ↑ Davis, Mellar; Maida, Vincent; Daeninck, Paul; Pergolizzi, Joseph (2006). "The emerging role of cannabinoid neuromodulators in symptom management". Supportive Care in Cancer 15 (1): 63–71. doi:10.1007/s00520-006-0180-0. PMID 17139494.
  7. ↑ World health Organization, Cannabis - epidemiology.
  8. 1 2 Galli, JA; Sawaya, RA; Friedenberg, FK (December 2011). "Cannabinoid hyperemesis syndrome.". Current drug abuse reviews 4 (4): 241–9. PMID 22150623.
  9. ↑ Lu, ML; Agito, MD (July 2015). "Cannabinoid hyperemesis syndrome: Marijuana is both antiemetic and proemetic.". Cleveland Clinic journal of medicine 82 (7): 429–34. PMID 26185942.
  10. ↑ King, Chelsey; Holmes, Andrew (2015-03-17). "Cannabinoid hyperemesis syndrome". CMAJ: Canadian Medical Association journal = journal de l'Association medicale canadienne 187 (5): 355. doi:10.1503/cmaj.140154. ISSN 1488-2329. PMC 4361109. PMID 25183721.
  11. ↑ Habboushe, Joseph; Sedor, Jennifer (2014-06-01). "Cannabinoid hyperemesis acute renal failure: a common sequela of cannabinoid hyperemesis syndrome". The American Journal of Emergency Medicine 32 (6): 690.e1–2. doi:10.1016/j.ajem.2013.12.013. ISSN 1532-8171. PMID 24418446.
  12. ↑ Wallace, Erik A.; Andrews, Sarah E.; Garmany, Chad L.; Jelley, Martina J. (2011-09-01). "Cannabinoid hyperemesis syndrome: literature review and proposed diagnosis and treatment algorithm". Southern Medical Journal 104 (9): 659–664. doi:10.1097/SMJ.0b013e3182297d57. ISSN 1541-8243. PMID 21886087.
  13. ↑ Sun, S; Zimmermann, AE (September 2013). "Cannabinoid hyperemesis syndrome.". Hospital pharmacy 48 (8): 650–5. PMID 24421535.

Further reading

This article is issued from Wikipedia - version of the Tuesday, December 15, 2015. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.